Market Overview

Why Moleculin Biotech's Stock Is Trading Higher Today

Why Moleculin Biotech's Stock Is Trading Higher Today

Moleculin Biotech Inc (NASDAQ: MBRX) shares are trading higher on Wednesday, after the company said that independent research found 2-deoxy-D-glucose (2-DG) to reduce replication of coronavirus by 100% in the Vitro Testing.

The company also noted the 2-DG is an active compound in its WP1122 Drug.

See Also: Moleculin Investors Rewarded As Annamycin Trial Advances To Next Cohort

Moleculin Biotech is a clinical-stage pharmaceutical company, focuses on the development of oncology drug candidates. Its lead drug candidate is Annamycin for the treatment of relapsed or refractory acute myeloid leukemia (AML) and lung-localized tumors.

Moleculin Biotech shares were trading higher by 170.13% to $1.52 at the time of publication. The stock has a 52-week high of $3.15 and a 52-week low of 32 cents.


Related Articles (MBRX)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at